Natalia Camejo-Martínez

11PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisOccupational therapyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 06, 2026
[Initial clinical experience with ribociclib in advanced HR+/HER2- breast cancer in Uruguay].

|May 05, 2025
Influence of different treatment modalities on the sexual function of breast cancer survivors: An observational ambispective study.

Natalia Camejo Martinez, Cecilia Castillo Leska, María Rosina Servetto Martinez

|Sep 24, 2024
Fulvestrant en la práctica clínica: análisis de efectividad en pacientes uruguayas con cáncer de mama HR+/HER2.

Natalia Camejo, Dahiana Amarillo, Cecilia Castillo

|Aug 07, 2024
[Cardiotoxicity from anti-HER-2 therapies in patients with HER-2 positive breast cancer].

Natalia Camejo-Martínez, Cecilia Castillo-Leska, Valeria Rodríguez-Saenz

|May 16, 2024
Efficacy of First-Line Treatment With Pertuzumab and Trastuzumab in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in Routine Clinical Practice.

Natalia Camejo, Cecilia Castillo, Dahiana Amarillo

|May 09, 2024
Implementing Standard Diagnosis and Treatment for Locally Advanced Breast Cancer Through Global Research in Latin America: Results From a Multicountry Pragmatic Trial.

Javier Retamales, Adrián Daneri-Navarro, Nora Artagaveytia

Pageof 2

Frequent Collaborators

9 joint publications

Cecilia Castillo-Leska

8 joint publications

Gabriel Krygier-Waltier

6 joint publications

Dahiana Lourdes Amarillo-Hernández

4 joint publications

Guadalupe Rocío Herrera Álvarez